RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight (RXST) management is scheduled to present at the Piper Sandler 38th Annual Healthcare Conference on December 1, 2026. The presentation is set for 4:00 p.m. ET in New York City. A live webcast and archived replay will be available on RxSight’s investor relations website.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., Nov. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to present at the Piper Sandler 38th Annual Healthcare Conference on Tuesday, December 1, 2026, at 4:00 p.m. ET in New York City. A live webcast of the presentation and an archived replay will be available on the Company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The Light Adjustable Lens™ system, comprised of the RxSight Light Adjustable Lens™ products (LAL™ and LAL+™), RxSight Light Delivery Device™ (LDD™), and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Light Adjustable Lens™, LAL™, LAL+™, Light Delivery Device™ and LDD™ are trademarks of RxSight, Inc.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com